1. Short‐duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study). (2nd February 2017) Authors: Sulkowski, Mark S.; Flamm, Steve; Kayali, Zeid; Lawitz, Eric J.; Kwo, Paul; McPhee, Fiona; Torbeyns, Anne; Hughes, Eric A.; Swenson, Eugene S.; Yin, Philip D.; Linaberry, Misti Journal: Liver international Issue: Volume 37:Number 6(2017) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis. Issue 5 (May 2017) Authors: Tapper, Elliot B.; Hughes, Michael S.; Buti, Maria; Dufour, Jean-Francois; Flamm, Steve; Firdoos, Saima; Curry, Michael P.; Afdhal, Nezam H. Journal: Transplantation Issue: Volume 101:Issue 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗